These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6250244)

  • 1. Response of cyclic nucleotides to stimulation by prostaglandin E1 and 5-hydroxytryptamine in stored human platelets.
    Kim BK; Steiner M; Baldini MG
    Thromb Res; 1980 Mar; 17(6):873-84. PubMed ID: 6250244
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
    Malmsten C; Granström E; Samuelsson B
    Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic nucleotides in platelet function.
    Haslam RJ; Davidson MM; Fox JE; Lynham JA
    Thromb Haemost; 1978 Oct; 40(2):232-40. PubMed ID: 216130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic nucleotides in hypertension.
    Hamet P; Franks DJ; Adnot S; Coquil JF
    Adv Cyclic Nucleotide Res; 1980; 12():11-23. PubMed ID: 6250345
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of epoxymethano analogues of prostaglandin endoperoxides on aggregation, on release of 5-hydroxytryptamine and on the metabolism of 3',5'-cyclic AMP and cyclic GMP in human platelets.
    Best LC; McGuire MB; Martin TJ; Preston FE; Russell RG
    Biochim Biophys Acta; 1979 Mar; 583(3):344-51. PubMed ID: 221045
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of blood platelet function by cyclic nucleotides.
    Haslam RJ; Davidson MM; Davies T; Lynham JA; McClenaghan MD
    Adv Cyclic Nucleotide Res; 1978; 9():533-52. PubMed ID: 208396
    [No Abstract]   [Full Text] [Related]  

  • 8. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1.
    Bowen R; Haslam RJ
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):424-33. PubMed ID: 1711604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Present status and prospects of platelet inhibitors].
    Yasunaga K
    Rinsho Ketsueki; 1976 Jun; 17(6):590-9. PubMed ID: 184313
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP induces synthesis of prostaglandin E1 in platelets.
    Dayal V; Colman RW; Prakash O; Bose AK; Sinha AK
    Biochim Biophys Acta; 1983 Sep; 759(3):129-36. PubMed ID: 6309248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of serotonin on cyclic nucleotides of human platelets.
    Agarwal KC; Steiner M
    Biochem Biophys Res Commun; 1976 Apr; 69(4):962-9. PubMed ID: 179543
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of prostaglandin E1 on rat gastric motility and cyclic nucleotide content.
    Shearin NL; Pancoe WL
    Experientia; 1976 Dec; 32(12):1553-4. PubMed ID: 191278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 and central cyclic nucleotides.
    Folco GC; Longiave D; Berti F; Fumagalli R; Paoletti R
    Adv Prostaglandin Thromboxane Res; 1976; 1():305-12. PubMed ID: 187044
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of platelet responsiveness through selective phosphorylation of plasma membrane proteins.
    Apitz-Castro R; De Murciano A
    Biochim Biophys Acta; 1978 Dec; 544(3):529-39. PubMed ID: 215226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced platelet cyclic AMP response to prostaglandin E1 in essential hypertension.
    Resink TJ; Bürgisser E; Bühler FR
    Hypertension; 1986 Aug; 8(8):662-8. PubMed ID: 3015795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP response to prostaglandin E1 in mononuclear cells from peripheral blood and synovial fluid of patients with rheumatoid arthritis.
    Zurier RB; Doty J; Goldenberg A
    Prostaglandins; 1977 Jan; 13(1):25-31. PubMed ID: 190647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion.
    Gerrard JM; Townsend D; Stoddard S; Witkop CJ; White JG
    Am J Pathol; 1977 Jan; 86(1):99-116. PubMed ID: 188341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion.
    Gallin JI; Sandler JA; Clyman RI; Manganiello VC; Vaughan M
    J Immunol; 1978 Feb; 120(2):492-6. PubMed ID: 202654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.